Dynamic Technology Lab Private LTD Travere Therapeutics, Inc. Transaction History

Dynamic Technology Lab Private LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$5.44 - $9.5 $82,802 - $144,599	15,221 New	15,221 $137,000
Q2 2023 Aug 14, 2023	BUY	$15.3 - $22.61 $61,154 - $90,372	3,997 Added 25.72%	19,537 $300,000
Q1 2023 May 12, 2023	BUY	$17.82 - $22.89 $276,922 - $355,710	15,540 New	15,540 $349,000
Q2 2022 Aug 12, 2022	BUY	$20.94 - $30.01 $45,439 - $65,121	2,170 Added 16.25%	15,520 $376,000
Q1 2022 May 16, 2022	BUY	$23.61 - $30.6 $315,193 - $408,510	13,350 New	13,350 $344,000
Q3 2021 Nov 15, 2021	SELL	$12.98 - $25.03 $421,447 - $812,699	-32,469 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$14.11 - $26.4 $458,137 - $857,181	32,469 New	32,469 $474,000

196

84.9M

776K

900K

Ticker TVTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,173,600
Market Cap $1.3B
Description
Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in gallbladders; Cholbam, a cholic a...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.